Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exercise vs Metformin in Prediabetes
NCT07061496Completed
- Start
- Aug 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of liquid metformin (Aspargo Labs) in prediabetes (2 arms). Primary endpoint: Glycated Hemoglobin at 12 weeks. Started Aug 2025; status: completed.
02
Drugs
liquid metformin (Aspargo Labs)
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT07061496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07061496.